United States Securities and Exchange Commission · EDGAR Accession 0001669191-26-000173

Form C-U

Offering Progress Update — Regulation Crowdfunding
Campaign file 020-34896
Issuer CIK 1750795
Raising via NetCapital Funding Portal Inc.

Aphios Pharma LLC

Limited Liability CompanyDEIncorporated 2018North Reading, MAaphios.com
Progress updateEnd of offering. Issuer closed its offering with estimated gross proceeds of $64,992. The foregoing is in regard only to the amount raised under the Section 4(a)(6) exemption.
A

The Offering

as disclosed in this filing
Common Stock
$3.44
$10,000
$617,999
October 1, 2025
Expired 256 days ago
$0max $617,999

Target is 2% of the maximum. Over-subscriptions accepted, allocated first-come, first-served basis.

B

Financial Condition

two fiscal years, as filed
Pre-revenueBurn increasing2 employees
Line itemMost recent FYPrior FYΔ
Revenue00
Cost of goods sold00
Net income(22,715)(822)▼ burn
Total assets00
Cash & equivalents00
Accounts receivable00
Short-term debt52,29139,583▲ 32%
Long-term debt00
Taxes paid00

Figures in USD as reported by the issuer. Securities offered in all 50 states.

C

Campaign Timeline

file 020-34896 · all filings under this campaign
Loading campaign history…